• Tuberculosis Cell Mediated Immunity Antigen Response (T-SPOTĀ®. TB) Test
  • Biopsy, Mediastinal Lymph Node
  • Levetiracetam, Serum
  • Carbon monoxide poisoning
  • Malignant neoplasm, renal pelvis (kidney)
  • Familial adenomatous polyposis
  • Oncotype DX, Breast Cancer
  • Measles (Rubeola) Antibody, IgM
  • Epidermal Nerve Fiber Density (ENFD)
  • B-Cell Lymphoma, FISH, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Oncology Pharmacogenetics (PGx) Gene Variation Panel
Medical Test

Methodology
Access to Oncology Pharmacogenetics (PGx) Gene Variation Panel is restricted.